Avid Bioservices Inc (CDMO)

[biopharm]

trying to connect the dots with these analysts... which we will be seeing much more from the next several months

Michael King used to work for Wedbush ... now he is with Roth Capital Partners via his linked in site:

http://www.linkedin.com/profile/view?id=15950113&authType=NAME_SEARCH&authToken=_KmG&locale=en_US&srchid=3f75b974-23e4-462f-914d-03757fc3c699-0&srchindex=1&srchtotal=3&goback=.fps_PBCK_michael+king+rodman+renshaw_*1_*1_*1_*1_*1_*1_*2_*1_Y_*1_*1_*1_false_1_R_*1_*51_*1_*51_true_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2_*2&pvs=ps&trk=pp_profile_name_link

Now... I don't believe Roth Capital... is affiliated with Rodman Renshaw but Michael G. King ( Rodman Renshaw ) was on a cc with Joe Pantignis ( our buddy from Roth Capital Partners ) just yesterday Aug 14 for another bio pharma Celsium

http://seekingalpha.com/article/807791-celsion-management-discusses-q2-2012-results-earnings-call-transcript?page=7&p=qanda&l=last

just trying to connect the dots for all these analysts... but word is spreading fast now it seems

Could Rodman Renshaw be getting on the good side of PPHM to try and add them to their Sept 9-11 "14th Annual Healthcare Conference" ... wait and see

http://www.rodmanandrenshaw.com/conferences?id=176